CTHRC1 was first reported as a novel secretory protein in injured and diseased arteries, and it is thought that CTHRC1 may act to inhibit collagen expression and promotes cell migration, both of which are essential functions for an invasive cancer[18]. Here, CTHRC1 is linked to cancer.